Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells
Open Access
- 1 February 1995
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 86 (2) , 208-216
- https://doi.org/10.1111/j.1349-7006.1995.tb03041.x
Abstract
Normal human monocytes were isolated in a nascent state by centrifugal elutriation and used for the study of interleukin‐1 (IL‐1) and interleukin‐1 receptor antagonist (IL‐1ra) expression. Neither IL‐1β nor IL‐1ra mRNA was present in monocytes just after the isolation, but they were induced simultaneously in response to various stimulants. In contrast, only IL‐1β mRNA was expressed in monocytic leukemia cell line JOSK‐1, while little or no IL‐1ra mRNA was detected even after stimulation. Dominant expression of IL‐1β over IL‐1ra was also observed in fresh leukemia cells including monocytic leukemias, i.e., IL‐1βmRNA was constitutively expressed in 26 out of 36 cases (72.2%), whereas IL‐1ra mRNA was present only in 8 cases (22.2%). The signal intensity of IL‐1βmRNA was stronger than that of IL‐1ra even in IL‐1ra‐positive cases. Apoptotic cell death of monocytes was significantly inhibited by IL‐1β, and it was enhanced by IL‐1ra. In fresh leukemia cells, 3H‐thymidine uptake was generally higher in IL‐1‐producing cases than in IL‐1ra‐producing cases, and was increased by the addition of IL‐1β in all cases tested. Cell proliferation was inhibited by either IL‐1ra or anti‐IL‐1β antibody in IL‐1‐producing cases, while it was enhanced by anti‐IL‐1ra antibody in IL‐1ra‐producing cases. These results suggest that the balance between IL‐1 and IL‐1ra is necessary for homeostasis of the mononuclear phagocytosis system. The imbalance between these two counter‐acting cytokines might contribute to the altered growth and accumulation of leukemic cells.Keywords
This publication has 53 references indexed in Scilit:
- High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's diseaseThe Lancet, 1992
- Interleukin-1 receptor antagonist in normal and psoriatic epidermis.Journal of Clinical Investigation, 1992
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Interleukin-1 derived from human monocytic leukemia cell line JOSK-I acts as an autocrine growth factorBiochemical and Biophysical Research Communications, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.Journal of Clinical Investigation, 1987
- Interleukin‐1 producing ability of leukaemia cells and its relationship to morphological diagnosisBritish Journal of Haematology, 1987